Difference between revisions of "ERF for Frambozadrine in rats"

From Testiwiki
Jump to: navigation, search
m
Line 88: Line 88:
  
 
It is not clear which of the plausible methods for estimating the result is the best. The discussion is ongoing. {{disclink|Which method is the best for dose-response estimation?}}
 
It is not clear which of the plausible methods for estimating the result is the best. The discussion is ongoing. {{disclink|Which method is the best for dose-response estimation?}}
 +
 +
<t2b index="Disease,Response metric,Exposure route,Exposure metric,Exposure unit,Threshold,ERF parameter,Observation" locations="ERF,Description" unit="?">
 +
</t2b>
  
 
===Non-parametric Bayesian estimation===
 
===Non-parametric Bayesian estimation===

Revision as of 09:57, 12 October 2012


Scope

Frambozadrine dose-response function in rats describes the long-term health impact(s) caused by frambozadrine as a function of dose in rats. This dose-response function applies only to continuous long-term exposures of frambozadrine (like in chronic studies).

Definition

Causality

Upstream variables not defined.

Data

Toxicological data about frambozadrine in rats.

Dose(mg/kg-day) Total no rats Hyperkeratosis
Male
0 47 2
1.2 45 6
15 44 4
82 47 24
Female
0 48 3
1.8 49 5
21 47 3
109 48 33

Plausible dose-response functions

Unit

probability of impact

Formula

Methods for estimating dose-responses

+ Show code

Result

It is not clear which of the plausible methods for estimating the result is the best. The discussion is ongoing. D↷

You have error(s) in your data:

Number of indices and result cells does not match

Non-parametric Bayesian estimation

Males and Females combined

Dose levels MLE Prior Posterior mean Variance
0 0.053 0.125 0.0571 0.0634
1.2 0.133 0.25 0.1052 0.0348
1.8 0.102 0.375 0.13 0.0241
15 0.091 0.5 0.154 0.021
21 0.064 0.625 0.1799 0.0551
82 0.511 0.75 0.4969 0.2762
109 0.687 0.875 0.687 0.2778